Order before 2:00 PM - your package will be shipped the same day!
Borrelia IgM antibodies are antibodies produced as part of an earlier immune response to Borrelia bacteria. IgM may be associated with more recent exposure, but antibody timing can vary, and early infection may not always produce detectable antibodies. Results should be interpreted together with clinical findings, timing of possible tick exposure and other relevant information.

IgM testing is important in the diagnosis of Lyme disease as it helps detect early infection. IgM antibodies to Borrelia burgdorferi typically appear within a few weeks of infection, making this test useful for identifying recent exposure to the tick-borne bacterium.
Individuals who have been bitten by a tick or have been in areas where Lyme disease is common and present with symptoms such as fever, rash (erythema migrans), fatigue, and joint pain should undergo IgM testing. Early detection is crucial for effective treatment.
Positive IgM results, especially when combined with symptoms and possible tick exposure, usually lead to prompt treatment with antibiotics. Early treatment is crucial to prevent the progression of Lyme disease to more severe stages that can affect the joints, heart, and nervous system.
False positives in IgM tests can occur due to cross-reactivity with other bacteria, previous infections, or certain autoimmune disorders. This is why positive results from an IgM test are usually confirmed with additional testing, such as the IgG antibody test or Western blot.
GetTested’s Lyme Disease Test (IgG/IgM) is a rapid test designed for the qualitative detection of antibodies against Borrelia burgdorferi in blood samples. The test detects both IgM and IgG antibodies, providing an indication of either a current or past exposure to the bacteria. Results are available within approximately 10 minutes.
24.99 GBP
